异动解读 | Mesoblast核心产品收入预期乐观,股价盘中大涨5.79%

异动解读
Feb 27

Mesoblast Ltd (MSB.AU) 今日盘中大涨5.79%,引起了市场的广泛关注。

消息面上,Mesoblast Limited预计其核心产品Ryoncil在2026财年的全年净收入将介于1.1亿美元至1.2亿美元之间,这一积极的财务预期反映了公司对产品商业化前景的信心,可能提振了投资者情绪。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10